With demand for its RNA interference meds booming, Alnylam Pharmaceuticals has commenced work to soup up its flagship ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the planned expansion of its state-of-the-art manufacturing facility in Norton, Massachusetts. The ...
Dr Lal PathLabs , one of India’s leading diagnostic chains, has launched Sovaaka, a new preventive healthcare and wellness ...
A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback